Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
MFS Research International B MRIBX
- NAV / 1-Day Return 21.93 / +0.18 %
- Total Assets 16.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.790%
- Distribution Fee Level Below Average
- Share Class Type —
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Closed
- TTM Yield 0.45%
- Turnover 16%
USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 10:18 PM GMT+0
Morningstar’s Analysis MRIBX
Will MRIBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 3.58 | 597.7 Mil | Healthcare |
Linde PLC | 3.44 | 573.7 Mil | Basic Materials |
Schneider Electric SE | 3.44 | 572.8 Mil | Industrials |
Lvmh Moet Hennessy Louis Vuitton SE | 2.68 | 447.4 Mil | Consumer Cyclical |
Nestle SA | 2.40 | 400.2 Mil | Consumer Defensive |
Roche Holding AG | 2.30 | 384.1 Mil | Healthcare |
Hitachi Ltd | 2.23 | 371.2 Mil | Industrials |
TotalEnergies SE | 1.74 | 290.7 Mil | Energy |
NatWest Group PLC | 1.64 | 272.9 Mil | Financial Services |
Euronext NV | 1.63 | 271.1 Mil | Financial Services |